Weekly Dose: flibanserin, the drug that gives women one extra sexually satisfying experience every two months


close up of half a woman's face
Weekly Dose: flibanserin, the drug that gives women one extra sexually satisfying experience every two monthsJayne Lucke, La Trobe UniversityThe United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015.Australia hasn’t followed suit, though

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous New funding for Australia’s HIV community
Next Community pharmacists need key HCH role: Guild